Los Angeles (1)

Advanced Malignant Skin Neoplasm (1)

Metastatic Malignant Skin Neoplasm (1)

Recruiting (1)

phase 1 (1)

University of Southern California (1)

National Cancer Institute (NCI) (1)

atezolizumab (1)

avelumab (1)

cemiplimab (1)

durvalumab (1)

nivolumab (1)

pembrolizumab (1)

quality-of-life assessment (1)

short-term fasting (1)

biological (1)

drug (1)

other (1)

Other (1)

Interventional (1)

advanced malignant skin neoplasm

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Apr 1, 2021